Weekly Secondary Recap (11.17.17)

IPO BOUTIQUE is one of the few syndicate services that provides ratings on all secondary offerings (Spots, blocks, marketed). We use our database of historical performances, underwriter trends and more than 40 years playing the syndicate service to give our clients a leg up. We meticulously keep records of our ratings. If interested please click below to inquire or email: JZell@IPOBoutique.Com

You can Subscribe to IPO Boutique’s Secondary Only Service by clicking here:

 

This past week 28 secondary offerings came to market and IPO Boutique placed BUY ratings on 14 of them. In all, $4.6bn was raised by companies in the secondary market this week.

The average gain of IPO Boutique BUY rated offerings this week at first trade was 2.6%

The average gain of IPO Boutique Neutral rated offerings this week at first trade was 2.2%.

The last 20 IPO Boutique ‘BUY’ rated secondary offerings have produced an average gain of 2.38% at first trade and an average gain of 6.74% at the high of their first-day of trading.

Equity capital markets were once again busy with a steady flow of offerings throughout the week.

The deal of the week was, hands-down, Mirati Therapeutics, Inc. ( MRTX). Underwritten by Cowen and Barclays…the offering priced at $13.00 giving a 7.5% discount to the last trade. MRTX opened at $14.00 and traded as high as $19.25 for a 48.2% gain at top tick. IPO Boutique rated this offering as a BUY.

A handful of marketed deals had solid performances. Floor and Decor (FND), Gardner Denver Holdings (GDI), JELD-WEN Holdings (JELD), and Presidio (PSDO) opened 2.1%, 2.3%, 2.7% and 5.1% above their offering prices, respectively. We rated the latter three with BUY ratings’.

After a couple difficult weeks for healthcare offerings…this week had a few bright spots. Achillion Pharma (ACHN) and Alnylam Pharmaceuticals, Inc being two of them. (ALNY) opened 18.5% and 4.0% higher. This is in addition to the highly successful MRTX offering.

The largest offering this week was the $600m raise from Gardner Denver Holdings. As previously mentioned, we rated GDI as a BUY and the deal closed 6.0% above the offering price.

There are currently no secondary offerings on the schedule for the upcoming week. We wanted to point out that we have added the VWAP to our Secondary Performance Report charts that are sent to Secondary Alerts clients on a daily basis. This was a request by a few of our clients and we are happy, as always, to take the extra step to satisfy your needs.